114 related articles for article (PubMed ID: 34714284)
1. Expression and Prognostic Value of Small Mothers Against Decapentaplegic 7, Matrix Metalloproteinase 2, and Matrix Metalloproteinase 9 in Resectable Pancreatic Ductal Adenocarcinoma.
Zhou L; Lu J; Liang ZY; Zhou WX; Wang YZ; Jiang BL; You L; Guo JC
Pancreas; 2021 Sep; 50(8):1195-1201. PubMed ID: 34714284
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic satellite cells derived galectin-1 increase the progression and less survival of pancreatic ductal adenocarcinoma.
Tang D; Zhang J; Yuan Z; Gao J; Wang S; Ye N; Li P; Gao S; Miao Y; Wang D; Jiang K
PLoS One; 2014; 9(3):e90476. PubMed ID: 24595374
[TBL] [Abstract][Full Text] [Related]
3. Low-level expression of Smad7 correlates with lymph node metastasis and poor prognosis in patients with pancreatic cancer.
Wang P; Fan J; Chen Z; Meng ZQ; Luo JM; Lin JH; Zhou ZH; Chen H; Wang K; Xu ZD; Liu LM
Ann Surg Oncol; 2009 Apr; 16(4):826-35. PubMed ID: 19165547
[TBL] [Abstract][Full Text] [Related]
4. High nuclear Survivin expression as a poor prognostic marker in pancreatic ductal adenocarcinoma.
Zhou L; Lu J; Liang ZY; Zhou WX; Yuan D; Li BQ; You L; Guo JC; Zhao YP
J Surg Oncol; 2018 Dec; 118(7):1115-1121. PubMed ID: 30261114
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological and prognostic significance of MKK4 and MKK7 in resectable pancreatic ductal adenocarcinoma.
Lu J; Zhou L; Yang G; Liang ZY; Zhou WX; You L; Yuan D; Li BQ; Guo JC; Zhao YP
Hum Pathol; 2019 Apr; 86():143-154. PubMed ID: 30537492
[TBL] [Abstract][Full Text] [Related]
6. High JAK2 Protein Expression Predicts a Poor Prognosis in Patients with Resectable Pancreatic Ductal Adenocarcinoma.
Song Y; Tang MY; Chen W; Wang Z; Wang SL
Dis Markers; 2020; 2020():7656031. PubMed ID: 33029256
[TBL] [Abstract][Full Text] [Related]
7. Yes-associated protein (YAP65) in relation to Smad7 expression in human pancreatic ductal adenocarcinoma.
Guo J; Kleeff J; Zhao Y; Li J; Giese T; Esposito I; Büchler MW; Korc M; Friess H
Int J Mol Med; 2006 May; 17(5):761-7. PubMed ID: 16596258
[TBL] [Abstract][Full Text] [Related]
8. PROX1 and β-catenin are prognostic markers in pancreatic ductal adenocarcinoma.
Saukkonen K; Hagström J; Mustonen H; Juuti A; Nordling S; Kallio P; Alitalo K; Seppänen H; Haglund C
BMC Cancer; 2016 Jul; 16():472. PubMed ID: 27411302
[TBL] [Abstract][Full Text] [Related]
9. Expression and prognosis value of SHP2 in patients with pancreatic ductal adenocarcinoma.
Zheng J; Huang S; Huang Y; Song L; Yin Y; Kong W; Chen X; Ouyang X
Tumour Biol; 2016 Jun; 37(6):7853-9. PubMed ID: 26695153
[TBL] [Abstract][Full Text] [Related]
10. Plasminogen Activator Inhibitor 1 as a Poor Prognostic Indicator in Resectable Pancreatic Ductal Adenocarcinoma.
Liu WJ; Zhou L; Liang ZY; Zhou WX; You L; Zhang TP; Zhao YP
Chin Med J (Engl); 2018 Dec; 131(24):2947-2952. PubMed ID: 30539907
[TBL] [Abstract][Full Text] [Related]
11. miR-367 promotes epithelial-to-mesenchymal transition and invasion of pancreatic ductal adenocarcinoma cells by targeting the Smad7-TGF-β signalling pathway.
Zhu Z; Xu Y; Zhao J; Liu Q; Feng W; Fan J; Wang P
Br J Cancer; 2015 Apr; 112(8):1367-75. PubMed ID: 25867271
[TBL] [Abstract][Full Text] [Related]
12. A comprehensive examination of Smad4, Smad6 and Smad7 mRNA expression in pancreatic ductal adenocarcinoma.
Singh P; Wig JD; Srinivasan R; Radotra BD
Indian J Cancer; 2011; 48(2):170-4. PubMed ID: 21768661
[TBL] [Abstract][Full Text] [Related]
13. Arpin downregulation is associated with poor prognosis in pancreatic ductal adenocarcinoma.
Zhang SR; Li H; Wang WQ; Jin W; Xu JZ; Xu HX; Wu CT; Gao HL; Li S; Li TJ; Zhang WH; Xu SS; Ni QX; Yu XJ; Liu L
Eur J Surg Oncol; 2019 May; 45(5):769-775. PubMed ID: 30416079
[TBL] [Abstract][Full Text] [Related]
14. Toll-like receptor 2 and Toll-like receptor 4 predict favorable prognosis in local pancreatic cancer.
Lanki MA; Seppänen HE; Mustonen HK; Böckelman C; Juuti AT; Hagström JK; Haglund CH
Tumour Biol; 2018 Sep; 40(9):1010428318801188. PubMed ID: 30246618
[TBL] [Abstract][Full Text] [Related]
15. Postoperative prognostic predictors of pancreatic ductal adenocarcinoma: clinical analysis and immunoprofile on tissue microarrays.
Park JK; Kim MA; Ryu JK; Yoon YB; Kim SW; Han HS; Kang GH; Kim H; Hwang JH; Kim YT
Ann Surg Oncol; 2012 Aug; 19(8):2664-72. PubMed ID: 22395988
[TBL] [Abstract][Full Text] [Related]
16. Identification of ANXA1 as a lymphatic metastasis and poor prognostic factor in pancreatic ductal adenocarcinoma.
Liu QH; Shi ML; Bai J; Zheng JN
Asian Pac J Cancer Prev; 2015; 16(7):2719-24. PubMed ID: 25854353
[TBL] [Abstract][Full Text] [Related]
17. RECK expression in pancreatic cancer: its correlation with lower invasiveness and better prognosis.
Masui T; Doi R; Koshiba T; Fujimoto K; Tsuji S; Nakajima S; Koizumi M; Toyoda E; Tulachan S; Ito D; Kami K; Mori T; Wada M; Noda M; Imamura M
Clin Cancer Res; 2003 May; 9(5):1779-84. PubMed ID: 12738734
[TBL] [Abstract][Full Text] [Related]
18. PD-L1 expression in pancreatic ductal adenocarcinoma is a poor prognostic factor in patients with high CD8
Yamaki S; Yanagimoto H; Tsuta K; Ryota H; Kon M
Int J Clin Oncol; 2017 Aug; 22(4):726-733. PubMed ID: 28314962
[TBL] [Abstract][Full Text] [Related]
19. CD24 and S100A4 expression in resectable pancreatic cancers with earlier disease recurrence and poor survival.
Lee SH; Kim H; Hwang JH; Shin E; Lee HS; Hwang DW; Cho JY; Yoon YS; Han HS; Cha BH
Pancreas; 2014 Apr; 43(3):380-8. PubMed ID: 24622067
[TBL] [Abstract][Full Text] [Related]
20. DEK protein overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma.
Sun J; Bi F; Yang Y; Zhang Y; Jin A; Li J; Lin Z
Oncol Rep; 2017 Feb; 37(2):857-864. PubMed ID: 27959420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]